Biomerica Says Japan OKd Its Prostate Test
- Share via
Biomerica Inc., a Newport Beach medical technology company, said Monday that the Japanese Ministry of Health has approved the company’s disposable prostrate cancer screening test for distribution and marketing.
The company said in a press release that the 10-minute test is designed to detect elevated blood levels of prostate specific antigen, an early warning indicator of prostate cancer.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
